
Accrual Culture: Top Points for Site Selection - Timelines
The GOG Foundation, Inc. would like to thank our commercial supporters for their support of the GOG GYN-LIVE Podcast:Corcept Therapeutics, GSK, Pfizer Oncology, Eli Lilly, Genmab, and Verastem ★ Su...
2 Huhti 20min

Accrual Culture: Top Points for Site Selection - Responsiveness
6 Maalis 17min

GOG-3101 | TroFuse-20 Clinical Trial Update
In this episode, we dive into GOG‑3101 TroFuse‑20—a Phase 3, randomized, active‑controlled, open‑label, multicenter study evaluating MK‑2870 monotherapy versus Treatment of Physician’s Choice as secon...
5 Maalis 13min

The GOG Highlight Reel - January 2026
The GOG Foundation, Inc. and GOG Partners are thrilled to present the “The GOG Highlight Reel”, an ongoing Education Series that showcases clinical trials and other newsworthy education, from major me...
20 Helmi 2h 15min

KEYNOTE-B96 FDA APPROVAL REVIEW
16 Helmi 19min

Accrual Culture: Top Points for Site Selection - Feasibility
5 Helmi 15min

2026 Cervical Cancer Awareness Month Wrap Up
30 Tammi 11min



















